Cargando…

SARS-CoV-2 infection in hospitalized children with type 1 and type 2 diabetes

CONTEXT: While diabetes is a risk factor for severe illness from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in adults, there is conflicting data surrounding the relationship between the virus and diabetic disease process in children. OBJECTIVE: This case series aims to il...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trieu, Connie, Sunil, Bhuvana, Ashraf, Ambika P., Cooper, Joshua, Yarbrough, April, Pinninti, Swetha, Boppana, Suresh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553361/ https://www.ncbi.nlm.nih.gov/pubmed/34729361 http://dx.doi.org/10.1016/j.jcte.2021.100271

Ejemplares similares

Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Variants on Short- and Mid-term Cardiac Outcomes in Multisystem Inflammatory Syndrome in Children
por: Pinninti, Swetha, et al.
Publicado: (2023)

Dyslipidemia in Pediatric Type 2 Diabetes Mellitus
por: Sunil, Bhuvana, et al.
Publicado: (2020)

Antiviral Treatment of Maternal and Congenital Cytomegalovirus (CMV) Infections
por: Pinninti, Swetha, et al.
Publicado: (2023)

Glycaemic control and outcomes in children with type 2 diabetes diagnosed at or before 10 years of age
por: Greenup, Erin, et al.
Publicado: (2020)

417. Cytomegalovirus (CMV) and Sexually Transmitted infections (STIs) During Pregnancy
por: Geetha Pinninti, Swetha, et al.
Publicado: (2019)

996 Predictors of Sensorineural Hearing Loss (SNHL) in Infants with Symptomatic Congenital CMV Infection
por: Pinninti, Swetha G., et al.
Publicado: (2014)

Diagnostic Test Accuracy of Urine C-peptide Creatinine Ratio for the Correct Identification of the Type of Diabetes: A Systematic Review
por: Pappachan, Joseph M, et al.
Publicado: (2022)

997 Saliva vs Urine PCR: The Ideal Sample for congenital CMV Screening and Diagnosis
por: Pinninti, Swetha G., et al.
Publicado: (2014)

Osteopetrorickets Presenting with Failure to Thrive and Hypophosphatemia
por: Freese, Jurhee, et al.
Publicado: (2020)

Novel therapeutic targets and agents for pediatric dyslipidemia
por: Sunil, Bhuvana, et al.
Publicado: (2021)

No evidence for distinct types in the evolution of SARS-CoV-2
por: MacLean, Oscar A, et al.
Publicado: (2020)

Pathophysiology of Type 2 Diabetes in Children and Adolescents
por: Valaiyapathi, Badhma, et al.
Publicado: (2020)

Inhibition of SARS–CoV-2 by type I and type III interferons
por: Felgenhauer, Ulrike, et al.
Publicado: (2020)

Case report: 11-ketotestosterone may potentiate advanced bone age as seen in some cases of Wiedemann-Steiner Syndrome
por: Buchanan, Katherine, et al.
Publicado: (2022)

Glycemic control and lipid outcomes in children and adolescents with type 2 diabetes
por: Barr, Mary Margaret, et al.
Publicado: (2019)

Concurrent diabetic ketoacidosis with hyperosmolality and/or severe hyperglycemia in youth with type 2 diabetes
por: Schmitt, Jessica, et al.
Publicado: (2020)

Type I interferon susceptibility distinguishes SARS-CoV-2 from SARS-CoV.
por: Lokugamage, Kumari G., et al.
Publicado: (2020)

Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV
por: Lokugamage, Kumari G., et al.
Publicado: (2020)

Evasion of Type I Interferon by SARS-CoV-2
por: Xia, Hongjie, et al.
Publicado: (2020)

SARS-CoV-2 Seroprevalence in Individuals With Type 1 and Type 2 Diabetes Compared With Controls
por: Goyal, Alpesh, et al.
Publicado: (2022)

SARS-CoV, MERS-CoV and SARS-CoV-2: A Diagnostic Challenge
por: Ezhilan, Madeshwari, et al.
Publicado: (2021)

Therapy of Type 2 Diabetes in Patients with SARS-CoV-2 Infection
por: Bielka, Weronika, et al.
Publicado: (2021)

Outcomes of patients hospitalized for COVID-19, secondary infections, antimicrobial use during SARS-CoV-2 delta and omicron variants
por: Srialluri, Swetha, et al.
Publicado: (2023)

Rapid diagnostics for SARS-CoV-2 virus: point-of-care testing and lessons learned during the pandemic
por: Nguyen, Trieu, et al.
Publicado: (2021)

Managing SARS-CoV-2 outbreak challenges in psychiatric hospitals of Bangladesh
por: Kushal, Sayedul Ashraf, et al.
Publicado: (2020)

Treatment of hyperglycemia not associated with NAFLD improvement in children with type 2 diabetes mellitus
por: Beauchamp, Giovanna, et al.
Publicado: (2022)

Lipoprotein(a) Concentrations Correlate With LDL-C in Children With Type 1 and 2 Diabetes
por: Foster, Christy, et al.
Publicado: (2021)

Immune response in SARS-CoV-2 infection: the role of interferons type I and type III
por: Portela Sousa, Caciane, et al.
Publicado: (2020)

Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection?
por: Rossi, Francesca, et al.
Publicado: (2020)

Graves’ disease following administration of second dose of SARS-CoV-2 vaccine
por: Goblirsch, Timothy James, et al.
Publicado: (2021)

Rapid inactivation of SARS-CoV-2 by titanium dioxide surface coating
por: Micochova, Petra, et al.
Publicado: (2021)

Development of vaccines for SARS-CoV-2
por: Ng, Wern Hann, et al.
Publicado: (2020)

Interplay between SARS-CoV-2 and the type I interferon response
por: Sa Ribero, Margarida, et al.
Publicado: (2020)

Validation of SARS-CoV-2 detection across multiple specimen types
por: Perchetti, Garrett A., et al.
Publicado: (2020)

Activation and evasion of type I interferon responses by SARS-CoV-2
por: Lei, Xiaobo, et al.
Publicado: (2020)

Antiviral activities of type I interferons to SARS-CoV-2 infection
por: Mantlo, Emily, et al.
Publicado: (2020)

Type I interferons and SARS-CoV-2: from cells to organisms
por: Bastard, Paul, et al.
Publicado: (2022)

Efficacy of an adenovirus type 5 vectored SARS-CoV-2 vaccine
por: Kennedy, Richard B
Publicado: (2022)

Type I and III interferon responses in SARS-CoV-2 infection
por: Kim, You-Me, et al.
Publicado: (2021)

Cell-Type Apoptosis in Lung during SARS-CoV-2 Infection
por: Liu, Yakun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h25nmp2fqfj3hshoinmm1ogshc